Reference health
Polymeric Nanoparticles for Increased Oral Bioavailability and Rapid Absorption Using Celecoxib as a Model of a Low-Solubility, High-Permeability Drug
25/25 checkable references clean · checked 2026-07-22
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
3 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 25 checked references that resolve
resolves10.1016/S1056-8719(00)00107-6
Drug-like properties and the causes of poor solubility and poor permeability
resolves10.1016/j.biopha.2004.02.001
Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs
resolves10.1023/A:1016212804288
A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability
resolves10.1002/jps.22217
The Developability Classification System: Application of Biopharmaceutics Concepts to Formulation Development
resolves10.1016/j.jbiotec.2004.06.007
Challenges and solutions for the delivery of biotech drugs – a review of drug nanocrystal technology and lipid nanoparticles
resolves10.1016/j.ijpharm.2008.07.023
Top-down production of drug nanocrystals: Nanosuspension stabilization, miniaturization and transformation into solid products
resolves10.1002/jps.2600840712
Population Characteristics of Cyclodextrin Complex Stabilities in Aqueous Solution
resolves10.1016/j.addr.2007.10.014
Enhancing intestinal drug solubilisation using lipid-based delivery systems
resolves10.1016/j.ijpharm.2004.08.001
The role of biopharmaceutics in the development of a clinical nanoparticle formulation of MK-0869: a Beagle dog model predicts improved bioavailability and diminished food effect on absorption in human
resolves10.1081/DDC-120030422
Nanoparticle Engineering Processes for Enhancing the Dissolution Rates of Poorly Water Soluble Drugs
resolves10.1016/S0939-6411(00)00076-X
Improving drug solubility for oral delivery using solid dispersions
resolves10.1016/S0169-409X(01)00098-9
Amorphous pharmaceutical solids: preparation, characterization and stabilization
resolves10.1021/mp8000793
Hydroxypropyl Methylcellulose Acetate Succinate-Based Spray-Dried Dispersions: An Overview
resolves10.1016/j.ijpharm.2008.05.003
High bioavailability from nebulized itraconazole nanoparticle dispersions with biocompatible stabilizers
resolves10.1016/S0022-3565(24)29580-X
Pharmacokinetics of Celecoxib after Oral Administration in Dogs and Humans: Effect of Food and Site of Absorption
resolves10.1016/j.ejca.2006.09.010
Celecoxib enhances doxorubicin-induced cytotoxicity in MDA-MB231 cells by NF-κB-mediated increase of intracellular doxorubicin accumulation
resolves10.1016/j.ijpharm.2009.04.038
Advantages of celecoxib nanosuspension formulation and transformation into tablets
resolves10.1208/s12249-009-9364-5
In Vitro and In Vivo Evaluation of Proniosomes Containing Celecoxib for Oral Administration
resolves10.1016/j.addr.2006.09.017
Freeze-drying of nanoparticles: Formulation, process and storage considerations☆
resolves10.1007/s11095-009-9852-z
Utility of Hydroxypropylmethylcellulose Acetate Succinate (HPMCAS) for Initiation and Maintenance of Drug Supersaturation in the GI Milieu
The 3 references without a DOI — listed, not checked
no DOI — not checkedBeyerinck RA, Bloom CJ, Crew MD, Friesen DT, Morgen MM, Smithey DT. Pharmaceutical compositions based on a) nanoparticles comprising enteric polymers and b) casein. World International Patent Office Application WO/2008/065502. 2008a.
no DOI — not checkedBeyerinck RA, Smithey DT, Miller WK, Morgen MM, Bloom CJ. Pharmaceutical compositions comprising nanoparticles and casein. World International Patent Office Application WO/2008/135852. 2008b.
no DOI — not checkedMiller WK, Smithey DT, Tadday R, Frankamp BL. Pharmaceutical compositions comprising nanoparticles and a resuspending material. World International Patent Office Application WO/2009/073215. 2009.
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1007/s11095-011-0558-7"><img src="https://citestamp.com/citestamped/10.1007/s11095-011-0558-7/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1007/s11095-011-0558-7)